BIT's 16th Annual Congress of International Drug Discovery Science & Technology-China 2018
★ Abstract Submission

The IDDST-China 2018 Scientific Committee is inviting the submission of scientific abstracts for proffered paper and poster sessions.

Authors are asked to submit abstracts under one of the following categories, but not limited:
Biochemistry Imaging
Biopharmaceuticals Immunology
Cancer Biology Lead Discovery & Profiling
Cardiology Medicinal Chemistry
Cell Biology Microbiology
Cellular Hit Identification Molecular Pharmacology
Chemistry Oncology
Clinical Development Pharmacokinetics
Clinical Pharmacology R&D
Clinical R&D Structural Biochemistry
DMPK Target Discovery
Drug Discovery & Development Toxicology
Drug Safety & Metabolism Translational Sciences
Enabling Technologies Virology

Abstracts must be in English and contain a maximum of 2800 characters with space in Microsoft Word. A data table may be included where required, but will count as 600 characters against the 2800 characters total. A maximum of 1 image file may also be included, but each image will count as 600 characters against the 2800 characters total. All abstracts accepted by the Scientific Committee will be published in the conference proceeding. The Scientific Committee will review all submitted abstracts, and will determine if an abstract is to be presented orally, by poster, or by publication only. 

Abstracts failing to meet minimum standards or are not relevant to this conference will be declined. Authors may submit multiple abstracts, but usually an individual will not be offered more than one oral presentation. 
News Release
Full Program Released 说明:
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organizations

Information Research Center of International Talent, SAFEA

Jinan Innovation Zone
Supporting Organizations

Ji'nan Branch of China Council for The Promotion of International Trade

University of South Australia

School of Biological Engineering, Qilu University of Technology

Operating Organizations
Official Travel Agency
Participating Organizations

Amgen, Inc.
Arrowhead Pharmaceuticals Inc.
Eisai Co., Ltd.
ChemDiv, Inc.
University of Queensland
Comenius University
Fountain Medical Development Ltd.,
McGill University
Pharmaron Inc.
Pfizer Inc.
Florida State University
Shanghai Jiaotong University School of Medicine
Leydig, Voit & Mayer, Ltd.
University of Pittsburgh
F. Hoffmann-La Roche
Tactical Therapeutics, Inc.
Leadscope Inc.
AbbVie Deutschland GmbH & Co. KG
Merck KGaA
Genentech, Inc.
Hamamatsu Photonics K.K.
University of Arizona
ChemDiv, Inc
AbMax Biotechnology Inc.
University Hospital Brno and Medical Faculty of Masaryk University
PSMMC, Riyadh
Boehringer Ingelheim Pharma GmbH & Co. KG
Global PKPD & Pharmacometrics, Eli Lilly and Company
Beijing Institute of Pharmacology and Toxicology
Auckland UniVersity
Cyclenium Pharma Inc.
Helmholtz Centre for Infection Research
University of Arizona
Medlab Clinical Pty Ltd.
National Institute of Biological Sciences, Beijing
Quinnipiac University/King Lee PhD, LCC
Novartis Institue of Biomedical Research
IriSys, LLC,
Private Clinic of Dermatovenerology Svidník
Saarland University
Cardiff University

Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609-826, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.